Daehwa Pharmaceutical
Pharmaceutical Manufacturing • 
495 Hanu-ro, Hoengseong-eup, Korea, Republic of • 11-20 Employees
Company overview
| Headquarters | 495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Gangwon-do, Republic of Korea, Hoengseong-gun, Gangwon-do 25228, KR |
| Phone number | +8225866451 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Dds(Drug Delivery System), Pharmaceutical Products(Api & Finished Prodcuts), Tdds(Transdermal Drug Delivery System), Affil, Affiliated Company In German And China., Exporting To More Than 20 Countries At Now, Additional 20 Countries On Registration. |
| Founded | 1984 |
| Employees | 11-20 |
| Socials |
Key Contacts at Daehwa Pharmaceutical
Young Kang
Ceo
Bang Ba
Director
Daehwa Pharmaceutical Email Formats
Daehwa Pharmaceutical uses 1 email format. The most common is {first name} (e.g., john@daehwagm.co.kr), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@daehwagm.co.kr | 100% |
About Daehwa Pharmaceutical
DAEHWA was established on Jan. of 1984 and listed in KOSDAQ(Stock market) since 2002. We are running 3 R&D centers and 4 Manufacturing facilities with philosophy of Respecting life / Protection of environment / Advanced Technology that leads pharmaceutical industry. We are tries to contribute to the health and well-being of human race. *R&D Center - Pankyo R&D Center: Mainly research on DDS(Drug Delivery System)/Natural products - Central R&D Center: Mainly research on impovement of products(Formulation and others) - Hyangnam R&D Center: Mainly research on synthesizing of API and others *Manufacturing facility - 1st factory: Mainly manufacturing for oral formulations(Tab. / Cap. / ODF) and external agents as ointment, cream and gel. - 2nd factory: Dedicated for manufacturing for TDDS(Transdermal drug delivery system) products as Patch, Plaster, Cataplasma - 3rd factory: Dedicated for anticancer as oral solution (Newly builted for DHP107 - world first oral paclitaxel solution) - Hyangnam Factory: Manufacturing for API and health supplementary and so on. Also, we are running 4subsidiaries company as below; - DH Horim: Pharmaceutical wholesaler - Redox-Bio: Synthesizing of HA(Hyaluronic acid)/PDRN/Glutachione and related trading - S-Med: Medical information system contents service - C-Tri: R&D and pharmaceutical manufacturer focusing on Bio-products Among out products, most important product is world first oral paclitaxel solution DHP-107(Project name). This product would be get approval in Korea around 3Q of 2016 for Gastric cancer as first indication. This product adopt the our platform technology DHLASED(DaeHwa Lipid-bAsed Self-Emulsifying Drug delivery system) as first project. For more details and other business cooperation oppotunity, please kindly contact to below email address; crispaul@dhpharm.co.kr (Mr. Paul/Young-Sang Cho - Manager of Overseas Business Dept. / Business Development) Thanks and best regards,
Daehwa Pharmaceutical revenue & valuation
| Annual revenue | $87,500,000 |
| Revenue per employee | $5,469,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $280,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Daehwa Pharmaceutical has 7 employees across 5 departments.
Departments
Number of employees
Funding Data
Daehwa Pharmaceutical has never raised funding before.
Daehwa Pharmaceutical Tech Stack
Discover the technologies and tools that power Daehwa Pharmaceutical's digital infrastructure, from frameworks to analytics platforms.
Miscellaneous
JavaScript libraries
SSL/TLS certificate authorities
Miscellaneous
Spain
United Kingdom
United States
Frequently asked questions
4.8
40,000 users
